Hartog JW - Search Results

1

Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.

Hartog JW, de Vries AP, Bakker SJ, Graaff R, van Son WJ, van der Heide JJ, Gans RO, Wolffenbuttel BH, de Jong PE, Smit AJ. Hartog JW, et al. Nephrol Dial Transplant. 2006 Aug;21(8):2263-9. doi: 10.1093/ndt/gfl132. Epub 2006 Apr 5. Nephrol Dial Transplant. 2006. PMID: 16597636

2

Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.

Hartog JW, Smit AJ, van Son WJ, Navis G, Gans RO, Wolffenbuttel BH, de Jong PE. Hartog JW, et al. Am J Kidney Dis. 2004 Jun;43(6):966-75. doi: 10.1053/j.ajkd.2004.02.008. Am J Kidney Dis. 2004. PMID: 15168376 Review.

3

Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.

Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son WJ, de Jong PE, Smit AJ. Hartog JW, et al. Ann N Y Acad Sci. 2005 Jun;1043:299-307. doi: 10.1196/annals.1333.037. Ann N Y Acad Sci. 2005. PMID: 16037252

4

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.

Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ. Meerwaldt R, et al. Among authors: hartog jw. J Am Soc Nephrol. 2005 Dec;16(12):3687-93. doi: 10.1681/ASN.2005020144. Epub 2005 Nov 9. J Am Soc Nephrol. 2005. PMID: 16280473

5

Clinical and prognostic value of advanced glycation end-products in chronic heart failure.

Hartog JW, Voors AA, Schalkwijk CG, Scheijen J, Smilde TD, Damman K, Bakker SJ, Smit AJ, van Veldhuisen DJ. Hartog JW, et al. Eur Heart J. 2007 Dec;28(23):2879-85. doi: 10.1093/eurheartj/ehm486. Epub 2007 Nov 5. Eur Heart J. 2007. PMID: 17986469

6

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.

Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ. Hartog JW, et al. Eur J Heart Fail. 2007 Dec;9(12):1146-55. doi: 10.1016/j.ejheart.2007.09.009. Eur J Heart Fail. 2007. PMID: 18023248 Free article. Review.

7

Advanced glycation endproducts in chronic heart failure.

Smit AJ, Hartog JW, Voors AA, van Veldhuisen DJ. Smit AJ, et al. Among authors: hartog jw. Ann N Y Acad Sci. 2008 Apr;1126:225-30. doi: 10.1196/annals.1433.038. Ann N Y Acad Sci. 2008. PMID: 18448821 Review.

8

Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients.

Hartog JW, Gross S, Oterdoom LH, van Ree RM, de Vries AP, Smit AJ, Schouten JP, Nawroth PP, Gans RO, van Son WJ, Bierhaus A, Bakker SJ. Hartog JW, et al. Transplantation. 2009 Apr 15;87(7):1069-77. doi: 10.1097/TP.0b013e31819d3173. Transplantation. 2009. PMID: 19352130

9

Simple noninvasive measurement of skin autofluorescence.

Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A. Meerwaldt R, et al. Among authors: hartog j. Ann N Y Acad Sci. 2005 Jun;1043:290-8. doi: 10.1196/annals.1333.036. Ann N Y Acad Sci. 2005. PMID: 16037251

10

Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.

Hartog JW, Hummel YM, Voors AA, Schalkwijk CG, Miyata T, Huisman RM, Smit AJ, Van Veldhuisen DJ. Hartog JW, et al. J Card Fail. 2008 Sep;14(7):596-602. doi: 10.1016/j.cardfail.2008.03.008. Epub 2008 May 27. J Card Fail. 2008. PMID: 18722326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters